Clinical Publishing, Sep 2008, Pages: 128
Breast Cancer: AnAtlasof Investigation and Management Meeting the needs of specialist surgeons, oncologists, radiologists, breast physicians and breast-care nurses, this atlas provides a
Jain PharmaBiotech, June 2012, Pages: 881
Annexin A5 as an imaging biomarker of cardiovascular disease
Cardiovascular MRI
Myocardial perfusion imaging
Implantable magnetic biosensors for detecting cardiac biomarkers
Applications of biomarkers
Jain PharmaBiotech, June 2012, Pages: 225
abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. Historical landmarks in the evolution of cytogenetics are reviewed since the first images of
Jain PharmaBiotech, June 2012, Pages: 809
Cancer classification using microarrays
Detection of loss of heterozygosity
Diagnosis of cancer ofan unknown primary
Diagnostics for detection of minimal residual disease
DNA repair biomarkers
Jain PharmaBiotech, June 2012, Pages: 1045
Molecular Diagnostics - Technologies, Markets and Companies This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public
Jain PharmaBiotech, June 2012, Pages: 616
complimentary to genomic approaches. Toxicoproteomics, i.e. the evaluation of protein expression for understanding of toxic events, is an important application of proteomics in preclincial drug safety. Use of
Research Facts Ltd, March 2009
options and the monitoring of treatment efficacy.
Tests are available for a wide variety of diseases and conditions ranging from cancer to cardiovascular disease to cystic fibrosis.
Molecular diagnostics
Global Industry Analysts, Inc., June 2006, Pages: 465
2000 (includes corresponding Graph/Chart) III-66
6d. Rest of Middle East III-67
A.Market Analysis III-67
Outlook III-67
Oil Olive Industry in Lebanon
An Overview III-67
B.Market Analytics III-68
